04/11/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

04/11/2024

Nov 4, 2024, 14:32 | Insight
Addressing disparities in childhood cancer - International Society of Paediatric Oncology
International Society of Paediatric Oncology shared a post on LinkedIn: "Thank you to Resolve Global Health…
Nov 4, 2024, 14:30 | Blog
OncoInfluencers to Follow on Social Media: Dr. Bente Mikkelsen
We’re pleased to spotlight Dr. Bente Mikkelsen, a key leader in global health and noncommunicable…
Nov 4, 2024, 14:27 | Blog
Hedley Lewis: The power of reading for children and teenagers undergoing cancer treatment
Hedley Lewis shared a post by Collett Dawson, Owner of The CoLabon Network, on LinkedIn: "Thank…
Nov 4, 2024, 14:16 | Blog
Mohit Manrao: How we can uphold the values of the holiday to create a better world
Mohit Manrao shared a post on LinkedIn: "Diwali, the festival of lights, is my favorite Holiday…
Nov 4, 2024, 14:04 | Insight
Raffaele Colombo: Insights from October: Advances in ADC research and cancer therapeutics
Raffaele Colombo shared a post on LinkedIn: "October was extremely busy yet incredibly rewarding: With Jamie…
Nov 4, 2024, 13:50 | Insight
Esra Bilir: Driving meaningful change in gynecologic oncology
Esra Bilir, Resident in the Department of Obstetrics and Gynecology at Universitätsklinikum Schleswig-Holstein, shared on…
Nov 4, 2024, 13:41 | Blog
AF1q as a promising new biomarker for neuroblastoma
St. Baldrick's Foundation posted on LinkedIn about recent paper by Julie D. Saba et al., titled…
Nov 4, 2024, 13:40 | Blog
Fumiko Ladd Chino: An amazing Boot Walk to End Cancer
Fumiko Ladd Chino posted on X: "It was an amazing Boot Walk this AM to…
Nov 4, 2024, 13:37 | Blog
Juan P. Alderuccio: BTK inhibitors and degraders in Lymphoma and Chronic Lymphocytic Leukemia
Juan P. Alderuccio, Lymphoma Physician at Sylvester Comprehensive Cancer Center, shared on X about recent…
Nov 4, 2024, 13:32 | Insight
Paolo Tarantino: The SERENA-2 phase 2 trial of camizestrant vs fulvestrant is out
Paolo Tarantino, Research Fellow at The Dana-Farber Cancer Institute, shared on X: “The SERENA-2 phase…
All: 61 Posts: 31 - 40
Special Coverage